The Parathyroid Hormone Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Parathyroid Hormone Market:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
In accordance with The Business Research Company’s Global Market Report for Parathyroid Hormone in 2024, the market has demonstrated a consistent and robust growth trajectory. Projections indicate a shift from $2.35 billion in 2024 to $2.43 billion in the same year, driven by a noteworthy compound annual growth rate (CAGR) of 3.5%. This expansion is rooted in historical factors such as the escalating prevalence of chronic kidney disease, heightened awareness surrounding parathyroid hormone-related disorders, burgeoning demand for parathyroid hormone analogs, augmented government funding dedicated to parathyroid hormone research, and an overall increase in disposable incomes.
Anticipating a continuous upward trajectory, the parathyroid hormone market is poised to burgeon to $3.5 billion by 2028, boasting a robust CAGR of 9.6%. The forthcoming growth is underpinned by several pivotal factors, including the expanding geriatric population, the proliferation of private healthcare sectors, the emergence of new indications, the paradigm shift towards precision medicine, heightened awareness regarding bone health, and the broadening accessibility to healthcare. Noteworthy trends in the forecasted period encompass advancements in parathyroid hormone testing methodologies, innovations in drug delivery mechanisms, the integration of digital health solutions, a surge in combination therapies, and an increased emphasis on sustainability and green initiatives.
The rise in the prevalence of osteoporosis is expected to drive the market for parathyroid hormones. Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which further leads to an increased risk of fracture. According to the International Osteoporosis Foundation, osteoporosis affects approximately 1.4 million Canadians, mainly postmenopausal women and the elderly. The parathyroid hormone, which is naturally produced by the body for regulating calcium levels, is used to reduce the risk of bone fracture in people with osteoporosis and is administered as a daily subcutaneous injection. The increase in osteoporosis is therefore expected to contribute to the growth of the parathyroid hormone market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp
The parathyroid hormone market covered in this report is segmented –
1) By Disease Type: Hypocalcaemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Othe End-Users
One instrumental innovation in the medical domain is the HEMAsavR, a sterile medical device engineered for the capture and transfer of blood. This cutting-edge technology is increasingly being adopted for the collection and salvage of blood during surgical procedures, providing clinicians with a swift response to unanticipated blood loss. The economic advantage lies in the ability to collect sterile, anticoagulated blood without necessitating specialized resources, thereby reducing upfront shed blood collection costs. This, in turn, leads to a decline in allogenic transfusions, ultimately culminating in improved patient outcomes, including reduced mortality rates, lower incidences of infections, and a diminished risk of multi-organ failure.
The parathyroid hormone market report table of contents includes:
1. Executive Summary
2. Parathyroid Hormone Market Characteristics
3. Parathyroid Hormone Market Trends And Strategies
4. Parathyroid Hormone Market - Macro Economic Scenario
5. Global Parathyroid Hormone Market Size and Growth.
.....
31. Global Parathyroid Hormone Market Competitive Benchmarking
32. Global Parathyroid Hormone Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Parathyroid Hormone Market
34. Parathyroid Hormone Market Future Outlook and Potential Analysis
35. Appendix
Related Reports:
https://topprnews.com/military-platform-electro-optics-market-report/
https://topprnews.com/military-power-solutions-market-report/
https://topprnews.com/military-sensors-market-size/
https://goodprnews.com/military-platform-electro-optics-market-report/
https://goodprnews.com/military-power-solutions-market-report/
https://goodprnews.com/military-sensors-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The Business Research Company published its Parathyroid Hormone Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Parathyroid Hormone market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the Parathyroid Hormone market’s segments- 1) By Disease Type: Hypocalcaemia, Hypoparathyroidism2) By End-User: Hospitals, Clinics, Other.
View Complete Report:https://www.thebusinessresearchcompany.com/report/parathyroid-hormone-global-market-report-2020-30-covid-19-growth-and-changeParathyroid Hormone Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.The global parathyroid hormone market is expected to decline from $1.78 billion in 2019 to $1.70 billion in 2020 at a compound annual growth rate (CAGR) of -4.4%.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges.
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reportsThe Parathyroid Hormone Global Market Report 2020-30 by The Business Research Company describes and explains the global parathyroid hormone market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The report evaluates the market across each region and for the major economies within each region.The Parathyroid Hormone Global Market Report 2021 covers parathyroid hormone market drivers, parathyroid hormone market trends, parathyroid hormone market segments, parathyroid hormone market growth rate, parathyroid hormone market major players, and parathyroid hormone market size.View Complete Report: https://www.thebusinessresearchcompany.com/report/parathyroid-hormone-global-market-report-2020-30-covid-19-growth-and-change The parathyroid hormone market report provides an in-depth analysis of the impact of COVID-19 on the global parathyroid hormone industry, along with revised market numbers due to the effects of the coronavirus and the expected parathyroid hormone market growth numbers 2021-2030.Parathyroid Hormone Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now:hhttps://www.thebusinessresearchcompany.com/sample.aspx?id=3427=smpThe global parathyroid hormone market is expected to grow from $1.72 billion in 2020 to $1.79 billion in 2021 at a compound annual growth rate (CAGR) of 4.1%.
The parathyroid hormone market is expected to reach $2.02 billion in 2025 at a CAGR of 3%.The report covers the parathyroid hormone market segments-1) By Disease Type: Hypocalcemia, Hypoparathyroidism.2) By End-User: Hospitals, Clinics, Other.3) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues.About The Business Research Company: The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research.
It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally.
Parathyroid glands are four small glands located at the back of your thyroid gland.
These glands produce parathyroid hormone which helps in controlling the calcium and phosphorous levels in the body.The single major disease of parathyroid glands is overactivity of one or more of the parathyroid lobes, which make too much parathyroid hormone, causing a potentially serious calcium imbalance.
Contact us for Parathyroid Tumor Treatment in Delhi, India.
The global Growth Hormone Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the growth hormone market include Novo Nordisk A/S, Pfizer Inc., Novartis AG, Eli Lily And Company, Merck KGaA, Ipsen S.A., Anhui Anke Biotechnology Co., Ltd, LG Chem Ltd., Ferring B.V., and Genetech Inc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Growth Hormone Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/growth-hormone-market/download-sampleMarket DynamicsThe global HGH market seems to be quite impressive due to surge in HGH deficiency diseases and increasing application of growth hormones for treating problems like idiopathic short stature, small for gestational age and Turner syndrome.
Other key market drivers are initiatives taken by firms and government bodies for increasing awareness about growth hormone deficiencies and its treatment.
Factors like upsurge in FDA approvals and substantial investment by drug manufacturers for R activities for developing novel drugs are also expected to drive the market significantly.
